Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:brimonidine
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2013 |
| gptkbp:ATCCode |
gptkb:D11AX21
|
| gptkbp:form |
gel
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mirvaso
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Galderma
|
| gptkbp:mechanismOfAction |
alpha-2 adrenergic receptor agonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:sideEffect |
gptkb:contact_dermatitis
flushing erythema |
| gptkbp:usedFor |
rosacea
|
| gptkbp:bfsParent |
gptkb:Galderma
|
| gptkbp:bfsLayer |
7
|